Insilico Medicine, Asia Genomics Partner on Longevity Research | GenomeWeb

NEW YORK (GenomeWeb) – Insilico Medicine announced today that it has partnered with Singapore-based molecular diagnostics firm Asia Genomics to develop biomarkers of aging and longevity for Asian populations.

Under the terms of the deal, the companies will identify personalized aging-related biomarkers based on individuals' age-annotated genomic and transcriptomic data. They also aim to develop an age-predicting algorithm that will be incorporated into multiple deep neural networks trained and tested on Asian blood chemistry samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.